Investor FAQs
Amyris delivers high-performance alternatives to petroleum, plant and animal-based products across a wide range of consumer and industry segments. Our products offer customers a way to reduce environmental impact with No Compromise® in performance or availability. We are making better chemistry biologically.
Amyris is an integrated renewable products company that is enabling the world’s leading brands to achieve sustainable growth. Amyris applies its innovative bioscience solutions to convert plant sugars into hydrocarbon molecules, specialty ingredients and consumer products. The company is delivering its No Compromise® products in focused markets, including specialty and performance chemicals, fragrance ingredients, and cosmetic emollients. We genetically modify microorganisms, primarily yeast, and use them as living factories in established fermentation processes to convert plant-sourced sugars into potentially thousands of target molecules.
Amyris trades on the NASDAQ Global Select Market under the ticker symbol AMRS.
Amyris was incorporated in California in 2003 and reincorporated in Delaware in 2010.
5885 Hollis Street, Suite 100
Emeryville, CA 94608
Main Phone: (510) 450-0761
Main Fax: (510) 225-2645
Amyris' fiscal year ends December 31.
On September 27, 2010, Amyris priced 5,300,000 shares of its common stock at $16.00 per share. These amounts do not reflect the 1 for 15 reverse stock split of Amyris common stock effected in June 2017.
Morgan Stanley & Co. Incorporated, Goldman Sachs & Company, and J.P. Morgan Securities, Inc. acted as book-running managers for the offering and Banco Itaú and Stifel Nicolaus Weisel acted as co-managers for the offering.
Amyris does not currently have a direct stock purchase plan.
As a company that trades publicly on the NASDAQ Global Select Market, Amyris shares can be bought and sold through your registered representative.
No, Amyris does not offer a Dividend Reinvestment Plan.
All stockholder phone calls and correspondence should be directed to the Shareholder Relations Call Center of our stock transfer agent at 1-800-468-9716, or if calling from outside the U.S. at 1-651-450-4064.
Stockholder correspondence (including address changes and transfers) can be sent to:
Mail
EQ Shareowner Services
PO Box 64874
St Paul, Minnesota 55164-0874
Overnight
EQ Shareowner Services
1110 Centre Pointe Curve, Suite 101
Mendota Heights, MN 55120-4100
All stockholder phone calls and correspondence should be directed to the Shareholder Relations Call Center of our stock transfer agent at 1-800-468-9716, or if calling from outside the U.S. at 1-651-450-4064.
Stockholder correspondence (including address changes and transfers) can be sent to:
Mail
EQ Shareowner Services
PO Box 64874
St Paul, Minnesota 55164-0874
Overnight
EQ Shareowner Services
1110 Centre Pointe Curve, Suite 101
Mendota Heights, MN 55120-4100
All stockholder phone calls and correspondence should be directed to the Shareholder Relations Call Center of our stock transfer agent at 1-800-468-9716, or if calling from outside the U.S. at 1-651-450-4064.
Stockholder correspondence (including address changes and transfers) can be sent to:
Mail
EQ Shareowner Services
PO Box 64874
St Paul, Minnesota 55164-0874
Overnight
EQ Shareowner Services
1110 Centre Pointe Curve, Suite 101
Mendota Heights, MN 55120-4100
For investor-related questions please contact:
Peter DeNardo
Director, Investor Relations and Corporate Communications
Amyris
investor@amyris.com
510-740-7481